Differential expression of a set of genes in follicular and classic variants of papillary thyroid carcinoma

Endocrine Pathology

Volumn 22, Issue 2, 2011, Pages 86-96

  Igci, Yusuf Ziya ^a   Arslan, Ahmet ^a   Akarsu, Ersin ^a   Erkilic, Suna ^a   Igci, Mehri ^a   Oztuzcu, Serdar ^a   Cengiz, Beyhan ^a   Gogebakan, Bulent ^a   Cakmak, Ecir Ali ^a   Demiryurek, A Tuncay ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Classic variant of papillary thyroid carcinoma; Differential display polymerase chain reaction; Follicular variant of papillary thyroid carcinoma; GeneMANIA; Papillary thyroid carcinoma

Indexed keywords

GENE PRODUCT; MINICHROMOSOME MAINTENANCE PROTEIN 3; PROTEIN ARPP19; PROTEIN BCL 6; PROTEIN DAD1; PROTEIN EFCAB5; PROTEIN EXOSC7; PROTEIN IK; PROTEIN KIAA1671; PROTEIN LOC284440; PROTEIN MFF; PROTEIN MPP1; PROTEIN NACA; PROTEIN POP1; PROTEIN PPP1R16A; PROTEIN PSMG1; PROTEIN RPL15; PROTEIN RPL7; PROTEIN SEPTIN 7; PROTEIN SMYD2; PROTEIN ZFP36L2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER PATIENT; CARCINOGENESIS; CLASSIC VARIANT PAPILLARY THYROID CARCINOMA; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; FEMALE; FOLLICULAR VARIANT PAPILLARY THYROID CARCINOMA; FUNCBASE; GENE EXPRESSION; GENE FUNCTION; GENE REGULATORY NETWORK; GENEMANIA; GENETIC ALGORITHM; GENETIC DATABASE; HUMAN; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THYROID NODULE; THYROID PAPILLARY CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; CARCINOMA, PAPILLARY; CARCINOMA, PAPILLARY, FOLLICULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROID NEOPLASMS; THYROID NODULE; YOUNG ADULT;

EID: 80051685678     PISSN: 10463976     EISSN: 15590097     Source Type: Journal    
DOI: 10.1007/s12022-011-9157-8     Document Type: Article

References (47)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics. CA Cancer J Clin. 58:71-96, 2008.
2. DeLellis RA. Pathology and genetics of thyroid carcinoma. Journal of Surgical Oncology 94:662-9, 2006.
3. Fagin JA, Mitsiades N. Molecular pathology of thyroid cancer: diagnostic and clinical implications. Best Practice & Research Clinical Endocrinology & Metabolism 22:955-69, 2008.
4. Barden CB, Shister KW, Zhu B, Guiter G, Greenblatt DY, Zeiger MA, Fahey TJ 3rd. Classification of follicular thyroid tumors by molecular signature: results of gene profiling. Clinical Cancer Research 9:1792-800, 2003. (Pubitemid 36554606)
5. Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med.118:282-9, 1993 (Pubitemid 23046388)
6. Shibru D, Chung KW, Kebebew E. Recent developments in the clinical application of thyroid cancer biomarkers. Current Opinion in Oncology 20:13-8, 2008. (Pubitemid 350190976)
7. Kato MA, Fahey TJ 3rd. Molecular markers in thyroid cancer diagnostics. Surgical Clinics of North America 89:1139-55, 2009.
8. Eszlinger M, Paschke R. Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns. Molecular and Celular Endocrinology 322:29-37, 2010.
9. Lee KY, Huang SM, Li S, Kim JM. Identification of differentially expressed genes in papillary thyroid cancers. Yonsei Medical Journal 50:60-7, 2009.
10. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257:967-71, 1992.
11. Sturtevant J. Applications of differential-display reverse transcription-PCR to molecular pathogenesis and medical mycology. Clinical Microbiology Reviews 13:408-27, 2000. (Pubitemid 30452614)
12. Chang KC, Komm B, Arnold NB, Korc M. The application of differential display as a gene profiling tool. Methods in Molecular Bioloy 383:31-40, 2007.
13. http://lukemiller.org/journal/2007/08/quantifying-western-blotswithout. html. Quantifying western blots without expensive commercial quantification software. (Access date: 05 October 2010)
14. Nikiforova MN, Nikiforov YE. Molecular diagnostics and predictors in thyroid cancer. Thyroid 19:1351-61, 2009.
15. Liang P. Factors ensuring successful use of differential display. Methods 16:361-4, 1998. (Pubitemid 29095116)
16. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Research 25:3389-402, 1997. (Pubitemid 27359211)
17. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S, ed. Bioinformatics Methods and Protocols: Methods in Molecular Biology. New Jersey: Humana Press, 2000; 365-386.
18. Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, Workman C, Christmas R, Avila-Campilo I, Creech M, Gross B, Hanspers K, Isserlin R, Kelley R, Killcoyne S, Lotia S, Maere S, Morris J, Ono K, Pavlovic V, Pico AR, Vailaya A, Wang PL, Adler A, Conklin BR, Hood L, Kuiper M, Sander C, Schmulevich I, Schwikowski B, Warner GJ, Ideker T, Bader GD. Integration of biological networks and gene expression data using Cytoscape. Nature Protocols 2:2366-82, 2007.
19. Beaver JE, Tasan M, Gibbons FD, Tian W, Hughes TR, Roth FP. FuncBase: a resource for quantitative gene function annotation. Bioinformatics 26:1806-7, 2010.
20. Mostafavi S, Ray D, Warde-Farley D, Grouios C, Morris Q. GeneMANIA: a real-time multiple association network integration algorithm for predicting gene function. Genome Biology Supplements 1 9:S4, 2008.
21. Tye BK. MCM proteins in DNA replication. Annual Review of Biochemistry 68:649-86, 1999. (Pubitemid 29449206)
22. Zhu M, Wang F, Yan F, Yao PY, Du J, Gao X, Wang X, Wu Q, Ward T, Li J, Kioko S, Hu R, Xie W, Ding X, Yao X. Septin 7 interacts with centromere-associated protein E and is required for its kinetochore localization. The Journal of Biological Chemistry 283:18916-25, 2008.
23. Lee YS, Ha SA, Kim HJ, Shin SM, Kim HK, Kim S, Kang CS, Lee KY, Hong OK, Lee SH, Kwon HS, Cha BY, Kim JW. Minichromosome maintenance protein 3 is a candidate proliferation marker in papillary thyroid carcinoma. Experimental and Molecular Pathology 88:138-42, 2010.
24. Giaginis C, Vgenopoulou S, Vielh P, Theocharis S. MCM proteins as diagnostic and prognostic tumor markers in the clinical setting. Histology and Histopathology 25:351-70, 2010.
25. Kebebew E, Peng M, Reiff E, Duh QY, Clark OH McMillan A. Diagnostic and prognostic value of cell-cycle regulatory genes in malignant thyroid neoplasms. World Journal of Surgery 30:767-74, 2006. (Pubitemid 43724104)
26. Madine MA, Swietlik M, Pelizon C, Romanowski P, Mills AD, Laskey RA The roles of the MCM, ORC, and Cdc6 proteins in determining the replication competence of chromatin in quiescent cells. Journal of Structural Biology 129:198-210, 2000. (Pubitemid 30481360)
27. Peter HJ, Gerber H, Studer H, Smeds S. Pathogenesis of heterogeneity in human multinodular goiter. A study on growth and function of thyroid tissue transplanted onto nude mice. The Journal of Clinical Investigation 76:1992-2002, 1985. (Pubitemid 16196075)
28. Salabé GB. Pathogenesis of thyroid nodules: histological classification?. Biomedicine & Pharmacotherapy 55:39-53, 2001. (Pubitemid 32178321)
29. Thomas GA, Williams D, Williams ED. Clonal origin of thyroid tumours. In: Wynford-Thomas D, Williams ED, ed. Thyroid tumours. Edinburg: Churchill Livingstone, 1989; 38-56.
30. Zhang P, Zuo H, Ozaki T, Nakagomi N, Kakudo K. Cancer stem cell hypothesis in thyroid cancer. Pathology International 56:485-9, 2006. (Pubitemid 44258848)
31. Sertel S, Eichhorn T, Sieber S, Sauer A, Weiss J, Plinkert PK, Efferth T. Factors determining sensitivity or resistance of tumor cell lines towards artesunate. Chemico-Biological Interactions 185:42-52, 2010.
32. Chevillard S, Ugolin N, Vielh P, Ory K, Levalois C, Elliott D, Clayman GL, El-Naggar AK. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications. Clinical Cancer Research 10:6586-97, 2004. (Pubitemid 39346555)
33. Yulug IG, See CG, Fisher EM, Ylug IG. The DAD1 protein, whose defect causes apoptotic cell death, maps to human chromosome 14. Genomics 26:433-5, 1995.
34. Kulke MH, Freed E, Chiang DY, Philips J, Zahrieh D, Glickman JN, Shivdasani RA. High-resolution analysis of genetic alterations in small bowel carcinoid tumors reveals areas of recurrent amplification and loss. Genes Chromosomes Cancer 47:591-603, 2008. (Pubitemid 351748345)
35. He H, Nagy R, Liyanarachchi S, Jiao H, LiW, Suster S, Kere J, de la Chapelle A. A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24. Cancer Research 69:625-31, 2009.
36. Kouniavsky G, Zeiger MA. Thyroid tumorigenesis and molecular markers in thyroid cancer. Current Opinion in Oncology 22:23-9, 2010.
37. Yotov WV, St-Arnaud R. Mapping of the human gene for the alpha-NAC/1.9.2 (NACA/1.9.2) transcriptional coactivator to Chromosome 12q23-24.1. Mammalian Genome 7:163-4, 1996. (Pubitemid 126426584)
38. Loeffen JL, Triepels RH, van den Heuvel LP, Schuelke M, Buskens CA, Smeets RJ, Trijbels JM, Smeitink JA. cDNA of eight nuclear encoded subunits of NADH:ubiquinone oxidoreductase: human complex I cDNA characterization completed. Biochemical and Biophysical Research Communications 253:415-22, 1998. (Pubitemid 29026717)
39. Woerner SM, Kloor M, Mueller A, Rueschoff J, Friedrichs N, Buettner R, Buzello M, Kienle P, Knaebel HP, Kunstmann E, Pagenstecher C, Schackert HK, Möslein G, Vogelsang H, von Knebel Doeberitz M, Gebert JF, German HNPCC Consortium. Microsatellite instability of selective target genes in HNPCCassociated colon adenomas. Oncogene 24:2525-35, 2005. (Pubitemid 40593043)
40. Nikiforov YE. Thyroid carcinoma: molecular pathways and therapeutic targets. Modern Pathology 21(2):S37-43, 2008. (Pubitemid 351592770)
41. Jackson RS 2nd, Cho YJ, Liang P. TIS11D is a candidate proapoptotic p53 target gene. Cell Cycle 5:2889-93, 2006. (Pubitemid 44953942)
42. Finley DJ, Arora N, Zhu B, Gallagher L, Fahey TJ 3rd. Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules. Journal of Clinical Endocrinology & Metabolism 89:3214-23, 2004. (Pubitemid 38951886)
43. Finley DJ, Zhu B, Barden CB, Fahey TJ 3rd. Discrimination of benign and malignant thyroid nodules by molecular profiling. Annals of Surgery 240:425-36; discussion 436-7, 2004.
44. Chuikov S, Kurash JK, Wilson JR, Xiao B, Justin N, Ivanov GS, McKinney K, Tempst P, Prives C, Gamblin SJ, Barlev NA, Reinberg D. Regulation of p53 activity through lysine methylation. Nature 432:353-60, 2004. (Pubitemid 39551664)
45. Huang J, Perez-Burgos L, Placek BJ, Sengupta R, Richter M, Dorsey JA, Kubicek S, Opravil S, Jenuwein T, Berger SL. Repression of p53 activity by Smyd2-mediated methylation. Nature 444:629-32, 2006. (Pubitemid 44864441)
46. Komatsu S, Imoto I, Tsuda H, Kozaki KI, Muramatsu T, Shimada Y, Aiko S, Yoshizumi Y, Ichikawa D, Otsuji E, Inazawa J. Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma. Carcinogenesis 30:1139-46, 2009.
47. Yin Y, Liu YX, Jin YJ, Hall EJ, Barrett JC. PAC1 phosphatase is a transcription target of p53 in signalling apoptosis and growth suppression. Nature 422:527-31, 2003. (Pubitemid 36433648)